Eğitim ve Araştırma Hastanesinde COVID-19 Pandemisinin ilk Üç Ayında Hasta Özelliklerinin Değerlendirilmesi ve Pandemi Yönetimi

Amaç: Samsun Eğitim ve Araştırma Hastanesinde COVID-19 şüpheli hastaların hastaneye yatış sürecinin değerlendirilmesi ve hastaların klinik özellikleri ile tedavi sürecinin ve başarısının değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: 18 Mart 2020 ve 29 Mayıs 2020 tarihleri arasında Samsun Eğitim ve Araştırma Hastanesi COVID-19 servisine COVID-19 hastalığı şüphesi ile yatırılan 284 hastanın verileri değerlendirildi. Bulgular: COVID-19 şüphesi ile yatan 284 hasta değerlendirildi. Hastaların yaş aralığı 18-95 arasında olup ortalama yaş 53 idi. Ortalama yatış günü 7.14 bulundu. 33 hasta (%11.6) COVID-19 reverse tran- scription polymerase chain reaction (RT-PCR) pozitif saptandı. 35 hastanın COVID-19 RT-PCR testi negatif olup bilgisayarlı tomografide (BT) buzlu cam görünümü nedeniyle yüksek klinik olasılıklı COVID-19 enfeksiyonu olarak değerlendiril- di. RT-PCR pozitif hastaların 10’unda radyolojik bulgu yoktu. Hastalar en fazla öksürük ve ateş yakınması ile başvurmuşlardı. Takip ettiğimiz 284 hastanın 68’i (%23.9) COVID-19 olarak kabul edildi. Sonuç: Hastaların hastaneye kabulünde daha çok klinik yakınmaları dikkate alınması ile gereksiz hasta yatışı sayısı fazla olmakla beraber COVID-19 RT-PCR pozitif hastalarda yaklaşık 1/3 oranında tomografi bulgusu izlenmemiştir. Mevcut tedaviler ile büyük oranda hastada klinik ve radyolojik düzelme görüldü.

Evaluation of Patient Characteristics and Pandemic Management in the First Three Months of the COVID-19 Pandemic at the

Aim: To evaluate the hospitalization process of suspect COVID-19 patients in Samsun Training and Research Hospital, to evaluate the clinical characteristics of the patients, the treatment process, and the success of the treatment. Material and Methods: The data from 284 suspected COVID-19 patients who were admitted to COVID-19 clinic at Samsun Training and Research Hospital between 18 March 2020 and 29 May 2020 were analyzed. Results: 284 suspect COVID-19 patients were evaluated. The age range of the patients was 18-95 and the mean age was 53. Average hospitalization days were 7.14. A definite diagnosis of COVID-19 was made in 33 patients (11.6%) due to reverse transcription polymerase chain reaction (RT-PCR) positivity. Although the RT-PCR test of 35 patients was negative, these patients were evaluated as COVID-19 with high clinical probability because of the ground glass opacities in harmony with COVID-19 in CT (Computed Tomography). There were no radiological findings in 10 of our RT-PCR positive patients. The patients mostly presented with complaints of cough and fever. 68 (23.9%) of 284 patients we followed were evaluated as COVID-19. Conclusion: The number of unnecessary hospitalizations was high due to the fact that clinical complaints were the main criteria for admission to the hospital. Yet, no CT finding was observed in about 1/3 of the RT-PCR positive patients. Clinical and radiological improvement was achieved in most of the patients using the treatments in hand.

PDF

___

1. Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan, China: Wuhan Municipal Health Commission. 2019-12-31. (In Chinese).
2. World Health Organization (2020) Novel coronavirus (2019- nCoV). Situation Report 22. 11 February 2020.
3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708-1720.
4. T.C. Sağlık Bakanlığı Halk Sağlığı Müdürlüğü “COVID-19 (2019-n CoV Hastalığı) Rehberi” (Bilim Kurulu Çalışması) 21 Şubat 2020.
5. T.C. Sağlık Bakanlığı Halk Sağlığı Müdürlüğü “COVID-19 (2019-n CoV Hastalığı Rehberi” (Bilim Kurulu Çalışması) 25 Mart 2020.
6. Zhao J, Yuan Q, Wang H. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020;71(16):2027-2034.
7. WHO Global surveillance for COVID-19 caused by human infection with COVID-19 virus. Interim guidance 20 March 2020.
8. WHO Laboratory testing for 2019 novel coronavirus (2019- nCoV) in suspected human cases. Interim guidance. 17 January 2020.
9. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020; 296: E32-E40
10. Bayraktaroğlu T, Kutlutürk F, Tekin S. The prognosis of “covid-19 pandemic and obesity: what we learned from the double pandemic? Turk J Diab Obes 2020; 2: 138-146.
11. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance 13 March 2020.